MetaCap

Lisata Therapeutics Statistics

NASDAQ: LSTAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.8989-0.0111 (-1.22%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Lisata Therapeutics by the numbers

Lisata Therapeutics has a market capitalization of $647,451 based on 720.27K shares outstanding. With trailing EPS of $-28.20, Lisata Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 95.0% below its 50-day average and 97.8% below its 200-day average.

Average daily trading volume is 13.46K shares, or about $12,096 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

LSTA valuation vs. peer median

LSTA compared with the median of 8 peer companies
MetricLSTAPeer medianDifference
Market cap$647.45K$799.54K-19%
Avg. volume13.46K547.80K-98%

Peer median across 8 companies: OGEN, SPRC, CDT, MTNB, BDRX, GOVX, SXTC, ARTL.

Valuation

Market cap
$647.45K
Price / sales (latest FY)
3.81
EPS (TTM)
$-28.20

Price and trading

Previous close
0.91
Open
0.8827
Day range
0.85 – 0.90
52-week range
0.85 – 76.05
52-week change
-54.14%
Beta
—
Volume
139.26K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
647.45K
Forward Pe
-0.77
Eps
-28.20
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
76.05
Week52 Low
0.85
Avg Volume
13,457.00
Shares Outstanding
720.27K
Ma50
18.08
Ma200
41.14
Earnings Date
Nov 5, 2026
Pct From52w High
-98.82%
Pct From52w Low
5.75%

Related